068760.KQ
Celltrion Pharm, Inc. [068760.KQ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
068760.KQ Stock Summary
Top 10 Correlated ETFs
068760.KQ
Top 10 Correlated Stocks
068760.KQ
In the News
068760.KQ Financial details
Company Rating
-
Market Cap
3988.3B
Income
21.26B
Revenue
388.79B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
888
Optionable
No
Shortable
Yes
Earnings
10 May 2024
P/E
206.24
Forward P/E
-
PEG
-114
P/S
20911.17
P/B
14.37
P/C
-
P/FCF
-852169.49
Quick Ratio
0.92
Current Ratio
1.25
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
513.43
EPS next Y
-
EPS next Q
-
EPS this Y
-18.09%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
18.68%
Revenue last 5Y
17.51%
Revenue Q/Q
1.9%
EPS Q/Q
-78.53%
-
-
-
-
SMA20
1.65%
SMA50
4.9%
SMA100
17.7%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
7%
ROC
0.07%
Gross Margin
31%
Oper. Margin
10%
Profit Margin
9%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
57714.285-133300.0
52W High
-52.14%
52W Low
+10.55%
RSI
57.66
Rel Volume
0.17
Avg Volume
370.02K
Volume
63.17K
Perf Week
7.41%
Perf Month
8.32%
Perf Quarter
19.25%
Perf Half Y
20.38%
-
-
-
-
Beta
0.395
-
-
Volatility
2212.3%, 1480.19%
Prev Close
0.31%
Price
63800
Change
-0.78%
Company Profile
- Volume Average 370.02K
- Market Capitalization 3988.3B
- Employee 888
- CEO Jung-su Seo
- Headquarters Cheongju,KR
- IPO Date 2006-02-03
-
Website
https://www.celltrionph.com 
Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju, South Korea.
